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Analysesofsomatichypermutation(SHM)patternsinBcellimmunoglobulin(Ig)sequences
contribute to our basic understanding of adaptive immunity, and have broad applications
not only for understanding the immune response to pathogens, but also to determining
the role of SHM in autoimmunity and B cell cancers. Although stochastic, SHM displays
intrinsic biases that can confound statistical analysis, especially when combined with the
particular codon usage and base composition in Ig sequences. Analysis of B cell clonal
expansion, diversiﬁcation, and selection processes thus critically depends on an accurate
background model for SHM micro-sequence targeting (i.e., hot/cold-spots) and nucleotide
substitution. Existing models are based on small numbers of sequences/mutations, in part
because they depend on data from non-coding regions or non-functional sequences to
remove the confounding inﬂuences of selection. Here, we combine high-throughput Ig
sequencing with new computational analysis methods to produce improved models of
SHM targeting and substitution that are based only on synonymous mutations, and are
thus independent of selection.The resulting “S5F” models are based on 806,860 Synony-
mous mutations in 5-mer motifs from 1,145,182 Functional sequences and account for
dependencies on the adjacent four nucleotides (two bases upstream and downstream of
the mutation).The estimated proﬁles can explain almost half of the variance in observed
mutation patterns, and clearly show that both mutation targeting and substitution are sig-
niﬁcantly inﬂuenced by neighboring bases.While mutability and substitution proﬁles were
highly conserved across individuals, the variability across motifs was found to be much
larger than previously estimated.The model and method source code are made available
at http://clip.med.yale.edu/SHM
Keywords: immunoglobulin, B cell, somatic hypermutation, mutability, substitution, targeting, AID, afﬁnity
maturation
1. INTRODUCTION
During the course of an immune response, B cells that initially
bind antigen with low afﬁnity through their immunoglobulin
(Ig)receptoraremodiﬁedthroughcyclesof proliferation,somatic
hypermutation (SHM), and afﬁnity-dependent selection to pro-
duce high-afﬁnity memory and plasma cells. Current models of
SHM recognize activation-induced deaminase (AID), along with
several DNA repair pathways, as critical to the mutation process
(1). AID initiates SHM by converting cytosines (Cs) to uracils
(Us), thus creating U:G mismatches in the Ig V(D)J sequence.
If not repaired before cell replication, these mismatches produce
C!T(thymine)transitionmutations(2).TheAID-inducedmis-
matches can alternatively be recognized by UNG or MSH2/MSH6
toinitiatebaseexcisionormismatchrepairpathways,respectively.
Thesepathwaysoperateinanerror-pronemannertointroducethe
full spectrum of mutations at the initial lesion, as well as spread-
ing mutations to the surrounding bases. Overall,SHM introduces
point mutations into the Ig locus at a rate of s10 3 per base-pair
per division (3, 4). While the process of SHM appears to be sto-
chastic, there are clear intrinsic biases, both in the bases that are
targeted(5,6)aswellasthesubstitutionsthatareintroduced(7,8).
Accurate background models for SHM micro-sequence targeting
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(i.e., hot/cold-spots) and nucleotide substitution would greatly
aid the analysis of B cell clonal expansion, diversiﬁcation, and
selectionprocesses.Inaddition,targetingandsubstitutionmodels
couldprovideimportantinsightsintotherelativecontributionsof
the various error-prone DNA repair pathways that mediate SHM.
Computational models and analyses of SHM have separated
the process into two independent components (7–11): (1) a tar-
getingmodelthatdeﬁneswheremutationsoccur(byspecifyingthe
relative rates at which positions in the Ig sequence are mutated),
and (2) a nucleotide substitution model that deﬁnes the resulting
mutation (by specifying the probability of each base mutating to
each of the other three possibilities). In experimentally derived
Ig sequences, observed mutation patterns are inﬂuenced by selec-
tion.Theafﬁnitymaturationprocessselectsforafﬁnity-increasing
mutations, while many mutations at structurally important posi-
tions in the framework regions are selected against (12). To avoid
the confounding inﬂuences of selection, most existing models
are built using mutation data from intronic regions ﬂanking the
V gene (13) and non-productively rearranged Ig genes (6–10,
14). These works have identiﬁed several speciﬁc motifs as being
“hot” or “cold” spots of SHM. Hot-spots include WRCY/RGYW
and WA/TW (where WD{A, T}, YD{C, T} RD{G, A}, and the
mutated position is underlined, see for example (5, 6)). Although
it has been argued that WRCH/DGYW (where H D{A, C, T} and
D D{A, G, T}) is a better predictor of mutability at C:G bases
(15).A single cold-spot motif has also been recognized: SYC/GRS
(where S D{C, G}) (16). Despite the wide recognition of these
speciﬁc hot-spot and cold-spot motifs, it is clear that a hierarchy
of mutabilities exists that is highly dependent on the surround-
ing bases (7, 10). More recently, it has been recognized that the
proﬁle of nucleotide substitutions may also be dependent on the
surrounding bases (8,17). Modeling SHM targeting and substitu-
tion is important for the analysis of mutation patterns since these
intrinsicbiasescangivetheappearanceof selectionduetothepar-
ticularcodonusageandbasecompositioninIgsequences(17,18).
Moreover,having such a model could shed light on the molecular
mechanisms underlying SHM, which are not fully understood.
Previous work has attempted to model the dependencies on
surrounding bases, but has been limited to (at most) the targeted
base and three surrounding bases (19), mainly due to the rela-
tively small data sets available. The use of intronic regions has
also limited the number of motifs that can be modeled (because
of the limited diversity of these regions), and non-productively
rearranged Ig genes may still be inﬂuenced by selection (e.g., if
theeventrenderingthesequencenon-productivehappenedinthe
course of afﬁnity maturation). In this study, we take advantage of
the wealth of data available from high-throughput Ig sequencing
technologies to build improved targeting and substitution mod-
els for SHM. To avoid the biasing effects of selection, we have
developed a new methodology for constructing models from syn-
onymous mutations only, thus avoiding the need to limit analysis
to non-productive Ig sequences. The increased data set size allows
modeling of dependencies on the surrounding four bases (two
bases upstream and downstream of the mutation). These “S5F”
(Synonymous,5-mer,Functional)modelsconﬁrmtheexistenceof
proposed hot- and cold-spots of SHM, but also show much more
extreme difference between hot- and cold-spots compared with
previousmodels.Wealsoﬁndthatthenucleotidesubstitutionpro-
ﬁlesatallbasesaredependentonthesurroundingnucleotides.The
S5F targeting and substitution models can be employed as back-
ground distributions for mutation analysis, such as the detection
and quantiﬁcation of afﬁnity-dependent selection in Ig sequences
(11,20). These models improve dramatically the ability to analyze
mutation patterns in Ig sequences, and provide insights into the
SHM process.
2. RESULTS
To develop models for SHM targeting and substitution pref-
erences, we curated a large database of mutations from high-
throughput sequencing studies (Table1). These data were derived
from 7 human blood and lymph node samples,and Ig sequencing
was carried out using both Roche 454 and Illumina MiSeq next-
generation sequencing technologies. In total, the data contained
42,122,509 raw reads, which were processed (see Materials and
Methods)toarriveat1,145,182“high-ﬁdelity”Igsequences,which
were each supported by a minimum of two independent reads in
a sample. These high-ﬁdelity sequences were clustered to identify
clones(sequencesrelatedbyacommonancestor)andoneeffective
sequence was constructed per clone so that each observed muta-
tion corresponded to an independent event. Overall, this process
produced a set of 806,860 synonymous mutations that were used
to model somatic hypermutation targeting and substitution.
2.1. THE NUCLEOTIDE SUBSTITUTION SPECTRUM IS AFFECTED BY
ADJACENT NUCLEOTIDES
A nucleotide substitution model speciﬁes the probability of each
base (A, T, G, or C) mutating to each of the other three possi-
bilities. For example, when a C is mutated, we might ﬁnd that
50% of the time it is replaced by T,while 30% of the substitutions
are to G, and the remaining 20% lead to A. These probabilities
may depend on the surrounding bases (i.e., the micro-sequence
context), as was previously suggested for mutations at A (17) and
more generally (8). To derive a nucleotide substitution model,the
set of mutations was ﬁltered to include only those that occurred
in positions where none of the possible base substitutions lead to
amino acid exchanges. Focusing on positions where only synony-
mousmutationswerepossibleremovestheconfoundinginﬂuence
of selection. The resulting 408,422 mutations were analyzed and
grouped into“5-mers”according to the germline sequence of the
mutatedpositionandsurroundingbases(twobase-pairsupstream
andtwobase-pairsdownstreamofthemutatedposition).Foreach
of the1024possible5-mers(M),asubstitutionmodelwasderived
bycalculatingSM
B ,theprobabilitythatthecentralbaseinthe5-mer
motif (M) mutates to base B. For example, in the 5-mer CCATC
mutations at A are always synonymous whenever this motif starts
a reading frame, in which case it codes for a Proline (CCA) fol-
lowed by a Serine (TCN). In this case, the number of observed
mutations that led to each of the other three possible nucleotides
(C, G, or T) was recorded: NCCATC
C , NCCATC
G , NCCATC
T . The maxi-
mum likelihood value for the probability that A is substituted by
base B is then calculated as:
SCCATC
B D
NCCATC
B
NCCATC
C C NCCATC
G C NCCATC
T
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Table 1 | Next-generation sequencing data sets used to construct the “S5F” targeting and substitution models.
Study Sample Subject Tissue Tech. Raw reads Processed reads Clones # Mutations (substitution) # Mutations (targeting)
1 3931LN 1 LN MiSeq 3,641,633 79,777 16,272 25,307 53,840
1 4014LN 2 LN MiSeq 3,714,152 106,006 32,972 57 ,215 106,265
1 4106LN 3 LN MiSeq 10,917 ,517 231,387 54,400 108,591 208,338
1 3928LN 4 LN MiSeq 7 ,691,509 99,519 76,375 68,051 132,795
2 PGP1-1 5 PBMC MiSeq 3,851,658 55,606 50,514 23,939 48,558
2 PGP1-2 5 PBMC MiSeq 3,946,514 59,611 54,374 24,971 50,117
2 PGP1-3 5 PBMC MiSeq 4,543,353 48,971 45,788 20,865 42,737
2 PGP1-4 5 PBMC MiSeq 3,121,884 52,844 49,054 23,243 47 ,049
3 hu420143 6 PBMC 454 178,584 92,055 14,956 23,260 48,838
3 420IV 7 PBMC 454 398,517 248,363 39,047 24,771 50,899
3 PGP1-5 5 PBMC 454 117 ,188 71,043 12,275 8,209 17 ,424
Total – – – – 42,122,509 1,145,182 446,027 408,422 806,860
Tissue types are lymph node (LN) or peripheral blood mononuclear cell (PBMC).The different ﬁlters applied to arrive at the number of (synonymous) mutations used
for the targeting and substitution models are described in the text. All three studies relate to manuscripts in preparation.
A bootstrapping procedure was used to estimate 95% conﬁdence
intervals (21).
Comparison of the substitution proﬁles for different 5-mer
motifs with the same central base clearly showed the signiﬁcant
inﬂuence of surrounding bases. As an example, Figure 1A shows
how the proﬁle of substitutions at G changes for several different
5-mers (ACGAT, GCGAG, GTGTA, and GGGAA). Such depen-
dencies were identiﬁed for every base (A, T, G, and C) (Figure 1B
and Figure S1 in Supplementary Material). The importance of
including two bases upstream and downstream was conﬁrmed by
comparingtheseproﬁleswithanalogousproﬁlesthatonlyaccount
for the immediately adjacent bases (3-mer motifs) (Figure 1A).
Forthe 3-merCGA,G!Cand G!Asubstitutions wereequally
likely (45% and 43% of substitutions, respectively), while G!C
substitutions were signiﬁcantly more likely than G!A in the
context of the GCGAG motif (51% and 35% of substitutions,
respectively). If one ignores neighboring nucleotides, the substi-
tution proﬁles were qualitatively similar to previous estimates (7),
although signiﬁcant quantitative differences were apparent (pre-
sumablyduetothemuchlargersizeof thedatasetcompiledhere).
Thus,nucleotidesubstitutionproﬁlesateverybasearesigniﬁcantly
affected by adjacent nucleotides, including at least two bases on
either side of the mutating base.
2.1.1. The complete substitution model for somatic hypermutation
is not strand-symmetric
It is not possible to estimate substitution proﬁles for all 5-mer
motifs using the above methodology because: (1) not all 5-mers
appear within the set of Ig sequences, and (2) some 5-mers (such
as NANNN) can never appear in a context where all substitutions
at the central (underlined) base are synonymous. Among the 11
datasets used here, these issues prevent estimation of the substi-
tution proﬁles for 717 of the 1024 5-mers. For the proﬁles that
could be directly estimated,there was a high correlation (on aver-
age Pearson RD0.63) between different individuals (Figures S2
and S3 in Supplementary Material), and so all the samples were
combined to estimate a single substitution model. To infer values
for the missing motifs, four methods were evaluated. In the ﬁrst
method (“inner 3-mer”),the substitution proﬁle for each missing
5-mer was inferred by averaging over proﬁles for all 5-mers with
the same 3-mer core (i.e., for which the middle three bases were
shared). In the second and third methods, missing values were
replaced by averaging over motifs sharing the two bases upstream
and downstream of the mutated base, respectively. In the fourth
method(“hot-spot”),themissingsubstitutionproﬁlewasinferred
by averaging over 5-mers sharing the two upstream bases when
the mutated position was “C” or “A,” and two downstream bases
when the mutated position was “G” or “T.” This ﬁnal option was
motivated by the dependencies of known “hot” and “cold” spots
for SHM targeting (5, 6). To choose between these four methods,
we compared their performance on 5-mers that could be directly
estimated from the data. Speciﬁcally, we calculated the correla-
tion between the inferred and directly estimated ratios for the
parameter R, which was deﬁned as the ratio between the highest
substitutionprobabilitywiththenexthighestoneforagiven5-mer
(Table 2). Pearson and Spearman coefﬁcients were both used in
order to be robust to the linear dependency assumption,and they
yielded comparable results. While the “hot-spot” method clearly
had the worst performance, the other three methods resulted in
very similar models. The “inner 3-mer” method produced the
highestPearsoncorrelation(0.4,seeTable2)andwaschosenasthe
basis to infer missing values.We refer to the resulting substitution
model as a “S5F” model since it is based on Synonymous muta-
tionsat5-mersinFunctionalIgsequences.Incontrasttoprevious
studies (8), there was no signiﬁcant correlation between substi-
tution values of 5-mers and their reverse complements (Pearson
correlation of 0.005, Spearman correlation of 0.087), suggesting
that at least one component of the substitution mechanism is not
strand-symmetric.
2.2. THE HIERARCHY OF MOTIF MUTABILITIES IS CONSERVED
ACROSS INDIVIDUALS
The mutability of a motif is deﬁned here as the (non-normalized)
probabilityof thecentralbaseinthemotif beingtargetedforSHM
relative to all other motifs. Similar to the substitution model,
the targeting model was based on 5-mer motifs, including the
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FIGURE 1 |The substitution proﬁle is signiﬁcantly inﬂuenced by
surrounding bases. Substitution proﬁles for various micro-sequence contexts
are shown for substitutions at (A) guanine and (B) adenosine, cytidine, and
thymidine. G: literature indicates values estimated by Smith et al. (7), while
S1F and RS1F refer to models estimated using the methods proposed here
using all (replacement and silent) or only silent mutations, respectively, and
averaging over surrounding bases. 3-mer motifs were estimated using silent
mutations and dependencies on the immediately adjacent bases (S3F), while
5-mer motifs refer to the complete S5F model. Horizontal lines in (A) indicate
the substitution values for the S1F model following the color scheme shown
in the legend. Motifs that fall into one of the standard hot or cold-spots
categories are indicated by the motif above the column.
Table 2 | Correlation coefﬁcients for inferring missing
mutability/substitution values.
Model Correlation Middle Upstream Downstream Hot
spots
Substitution Pearson 0.40 0.37 0.15 0.04
Spearman 0.20 0.24 0.23 0.09
Mutability Pearson 0.58 0.57 0.61 0.73
Spearman 0.61 0.58 0.64 0.79
two nucleotides immediately upstream and downstream of the
mutated base. The use of a 5-mer model is motivated by the
well-known WRCY hot-spot (where the underlined C is targeted
for mutation),and its reverse-complement (RGYW) which,when
taken together, create dependencies with the two bases on either
side of the mutating base.
Whenestimatingthemutability()foramotif(M),itiscritical
to account for the background frequency of M. To see why this is
thecase,considertheextremeexampleof asequencecomposedof
allCnucleotides.SinceallmutationswilloccuratCCCCCmotifs,
one might consider this motif a hot-spot, except that its back-
ground frequency is 100% so it is actually targeted at the expected
frequency. When calculating mutabilities it is also important to
avoid statistical artifacts due to heterogeneity (e.g., the Simpson
paradox (22)). Thus,Ig sequences were ﬁrst analyzed individually
since each has a different background 5-mer distribution. These
individual-sequence targeting models were then combined into a
singleaggregatedtargetingmodelforeachdataset.Estimatingthe
relative mutabilities of 5-mer motifs for an individual Ig sequence
involvestwosteps:(1)Calculatingthebackgroundfrequencyofthe
different5-mersbasedonthegermline(unmutated)versionofthe
sequence,and (2) creating a table of the 5-mers that were mutated
in the sequence. To avoid the confounding inﬂuence of selection,
only mutations that were synonymous (i.e., that do not produce
an amino acid exchange in the germline context) were included
in the analysis. Note that these criteria are slightly different from
those used in the substitution model. In the substitution model,
mutations were used only where all possible mutations at that
position had to be synonymous, while all synonymous mutations
were considered for mutabilities (see Table 1).
For each of the 1024 possible 5-mers motifs (M) in each
Ig sequence, the background frequency (BM) was calculated as
follows:
BM D
X
i
X
b
SM
b I  !
GL.i,M,b/ (1)
where i is summed over all (non-N) positions in the Ig sequence,
M is the 5-mer nucleotide sequence centered at position i and b
includes all possible nucleotides ({A, C, T, G}). In this equation
GL is a vector containing the nucleic content of each position in
the germline sequence, SM
b is the relative rate at which the center
nucleotide in M (GL[i]) mutates to b (as estimated in the previ-
ous section,and where SM
GLTiU D 0) and I  !
GL(i,M,b) is an indicator
function that is 1 in cases where the 5-mer surrounding GL[i]
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is M and a mutation in position i from GL[i] to b results in a
synonymous mutation (and 0 otherwise).A similar array was also
calculated for the mutated positions:
CM D
X
i
I  !
GL,
  !
OS.i,M/ (2)
where i is summed over all (non-N) positions in the observed Ig
sequence (OS), and the indicator function I  !
GL,
  !
OS (i, M) is 1 in
cases where the 5-mer surrounding GL[i] is M and a mutation in
position i from GL[i] to OS[i] is synonymous and 0 otherwise.
After calculating the arrays E C and E B, a mutability score, , was
deﬁned for each motif M in the vector (for sequence j) as:

j
M D C
j
M=B
j
M (3)
which was then normalized to one:
N 
j
M D 
j
M=
X
m

j
m (4)
where m is an index spanning all positions in E j. Note that 
j
M
is not deﬁned wherever B
j
M D 0 (i.e., the motif M does not
appear in the Ig sequence, or can not admit any synonymous
mutations). Finally,a single mutability score is generated for each
5-mermotif (M)astheweightedaverageof themutabilitiesscores
for each sequence j (N 
j
M), where weights correspond to the num-
ber of synonymous mutations in the sequence .
P
M C
j
M/. This
process resulted in an array of (relative) mutabilities,M for each
of the 5-mers observed in the dataset. The resulting vector was
renormalized so that the mean mutability was one.
2.2.1. Inference of missing values to complete targeting model
It was not possible to estimate mutabilities for 468 of the 1024
possible 5-mer motifs because not all 5-mers appeared within
the set of Ig sequences. The same four methods tested for infer-
ring missing values in the substitution model were also tested to
infer these mutabilities (see 2.1.1 and Table2). The“inner 3-mer”
method produced a Pearson correlation of 0.58 (0.61 for Spear-
man),while the“hot-spot”method had a correlation of 0.73 (0.79
for Spearman). Thus, in contrast to the nucleotide substitution
model, mutabilities were best predicted by averaging over 5-mers
which shared the two upstream bases when the mutated position
was “C” or “A,” and two downstream bases when the mutated
position was“G”or“T.”This result is consistent with the expected
inﬂuence of the classic SHM hot-spot (WRCY/RGYW).
2.2.2. Targeting is conserved across individuals
To test whether the micro-sequence speciﬁcity of SHM was
conserved across individuals,separate targeting models were con-
structed for each of the 11 samples in our study (Table 1). Com-
parisonof themotif mutabilitiesbetweenpairsof samplesshowed
that the models were highly consistent, with Pearson correlation
s0.9 (Figure 2 and Figure S4 in Supplementary Material). Thus,
we combined the data from all of the samples and generated a
single targeting model, with conﬁdence intervals based on the
middle 50% quantiles of the mutability across samples. As with
the substitution model,we refer to this targeting model as a“S5F”
model. In order to visualize this model, we created “hedgehog”
plots to display the directly estimated mutability values and the
complete S5F model (Figures 3A,B, respectively).
2.2.3. The true “hotness” of SHM hot-spots
Visual inspection of the “hedgehog” plots (Figure 3B) shows
clearly that the S5F model is consistent with known micro-
sequence preferences for SHM (5, 6). WRC/GYW and WA/TW
hot-spotmotifsaregenerallymoremutable,whileSYC/GRScold-
spot motifs generally show the lowest mutability. However, the
mutability of “hot-spot” motifs was observed to be highly vari-
able. There is a 62.7-fold difference between the most mutable
(GGGCA, mutabilityD9.56) and least mutable (TGCGA, muta-
bilityD0.15) WRC/GYW hot-spot motif. Indeed, s10% of so-
called“hot-spots”had mutabilities that were lower than the mean
mutabilityfor“neutral”motifs(Figure4A).Thishighvariancewas
especially obvious when looking at the subset of WRCA/TGYW
hot-spot motifs, and may help explain why WRCH/DGYW has
been proposed to be a better predictor of mutation at C:G com-
pared with WRCY/RGYW (15). The mutabilities estimated by
the S5F approach paint a qualitatively different picture of SHM
whencomparedwiththoseestimatedbytheexistingtri-nucleotide
model of Shapiro et al. (10). In the S5F model, the average
mutabilityof motifsthatcorrespondtotheWRC/GYWSHMhot-
spot was 3.2-fold higher than neutral motifs, and 9.6-fold higher
than the mutability of motifs corresponding to the cold-spot
SYC/GRS (Figure 4A). Using the tri-nucleotide model, hot-spots
were only 1.3-fold and 1.6-fold more mutable than neutral and
cold-spots, respectively (Figure 4B). In addition, in direct oppo-
sition to the S5F model, the tri-nucleotide method predicted that
A/T hot-spots (WA/TW) were more mutable than C/G hot-spots
(WRC/GYW). The mutabilities estimated by the S5F model bet-
ter predicted the positional-distribution of in vivo mutations. The
Pearsoncorrelationbetweentheexpectedmutabilityandobserved
mutationfrequencycalculatedoverIMGT-numberedpositionsin
12,000sequencesderivedfromavarietyof germlinesegmentswas
0.67 and 0.47 for the S5F and tri-nucleotide models, respectively
(Figure5andFigureS5inSupplementaryMaterial).Inbothmeth-
ods, deviations from the expected frequencies that likely reﬂect
both positive and negative selection were observed (Figure 5).
The observation of position-speciﬁc signals suggests that there is
something generic about the Ig structure at these positions, and
may help reﬁne traditional deﬁnitions of the complementarity
determining regions (CDR) and framework regions (FWR) (see
also (23)). Consistent with previous studies (24), the S5F model
displayed signiﬁcant strand-bias at A/T hot-spots, but not C/G
hot-spots (Figure 6). Overall, the S5F targeting model provides a
newviewof SHMwithhot-spotsbeingsigniﬁcantlymoretargeted
(and signiﬁcantly more variable) than previously thought.
3. MATERIALS AND METHODS
3.1. HIGH-THROUGHPUT IG SEQUENCING DATA SETS
A total of 11 human Ig repertoires were sequenced from blood
and lymph node samples from 7 different individuals. Next-
generation sequencing was carried out using Illumina MiSeq 250
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FIGURE 2 |The S5F targeting model is consistent across individuals.
Targeting models were constructed independently for each of the samples
listed inTable 1. Estimated values for all 5-mer motifs derived using lymph
node samples from three individuals (3931LN, 4014LN, and 4106LN) are
shown along the diagonal. Mutability values are ranked (from lowest to
highest) and color coded by their category (WRC/GYW are red, SYC/GRS are
blue, WA/TW are green, and the rest are gray). Symbols indicate the mutated
nucleotide (in the center of the 5-mer). Correlations between the mutabilities
for all 5-mer motifs across individuals are shown in the upper (log-log scale)
and lower (linear scale) triangles.
base-pair paired-end reads (8 samples) and Roche/454 GS FLX
(3 samples). Details are provided in Table 1. These samples were
originallycollectedandsequencedaspartof threeongoingstudies
(manuscripts in preparation).
3.1.1. Illumina MiSeq data
Human lymph node specimens were collected under an exempt
protocol approved by the Human Research Protection Program at
YaleSchoolof Medicine.Tissueswereprocessed andRNAisolated
as previously described (25). Blood samples were collected under
the approval of the Personal Genome Project (26). Total RNA
was immediately extracted from each blood sample and stored
at  80°C until use. To carry out sequencing, mRNA was reverse
transcribed into cDNA using gene-speciﬁc primers mapping to
the constant region of the Ig heavy chain. Resultant cDNA was
taggedwith17nucleotidesingle-moleculebarcodesandampliﬁed
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FIGURE 3 | “Hedgehog” plots for the S5F targeting model for somatic
hypermutation targetingA,T, C, and G nucleotides (individual circles).
(A) 5-mer mutabilities estimated directly from the Ig sequencing data. (B)The
complete S5F targeting model after inferring values for missing 5-mer motifs.
Bars radiating from each circle depict the mutability as a function of
surrounding bases.The inner-most ring in the circle corresponds to two
positions upstream (5
0) of the mutated base for A and C, and two positions
downstream (3
0) of the mutated base forT and G. Bar colors indicate known
hot/cold-spot motifs (WRC/GYW are red, WA/TW are green, SYC/GRS are
blue, and “neutral” are gray). Each plot corresponds to a different mutated
nucleotide. Error bars indicate conﬁdence intervals based on the middle 50%
quantiles of the mutability value distribution across the set of samples.
by PCR in a multiplex reaction using primer sets for all possi-
ble V-regions (n D45) and isotype/J-regions (n D6) to generate
heavy chain transcripts. The ampliﬁed library was tagged with
barcodes for sample multiplexing, PCR enriched, and annealed
to the required Illumina clustering adapters. High-throughput
250 base-pair paired-end sequencing was performed using the
Illumina MiSeq platform. Raw reads were exported without the
sample barcodes and Illumina clustering adapters.
3.1.2. Roche/454 GS FLX data
Blood samples were collected under the approval of the Personal
Genome Project (26). Total RNA was immediately extracted from
each blood sample and stored at  80°C until use. Ig heavy chain
mRNA were reverse-transcribed using a pool of 6 primers spe-
ciﬁc to the Ig constant regions and cDNA was ampliﬁed using
16 cycles of PCR with a pool of 46 V-region-speciﬁc primers
and 6 nested constant region primers. Following ligation of 454-
compatible sequencing adapters,the expected heavy chainV gene
fragments were puriﬁed using PAGE. Each sample was uniquely
barcoded during the ligation process, allowing subsequent mix-
ing of all the samples into one common reaction sample (per-
formed independently for each replicate run). Emulsion PCR
and 454 GS FLX sequencing were performed directly at the 454
Life Sciences facility according to the manufacturer’s standard
protocols.
3.2. SEQUENCING DATA PRE-PROCESSING
Raw sequencing reads were ﬁltered in several steps to identify
and remove low-quality sequences. Conservative thresholds were
applied in all cases to increase the reliability of the resulting
mutation calls, at the potential expense of excluding some real
mutations. Pre-processing was carried out using the Repertoire
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FIGURE 4 |The hierarchy of hot/cold-spot motifs. Mutability
values predicted by the (A) S5F model or (B) the tri-nucleotide
model of Shapiro et al. were grouped by the type of motif. Boxes
borders correspond to the ﬁrst and fourth quartiles while the
horizontal bar inside the box corresponds to the median of the
distribution. Hot/cold spot motif groups are plotted using the same
colors as in Figure 3B with open boxes. WRCN/NGYW motifs are
plotted using ﬁlled boxes.
SequencingToolkit(pRESTO)(http://clip.med.yale.edu/pRESTO,
manuscript in preparation), and involved:
 Quality control
1. Removal of low-quality reads (mean Phred quality score
<20).
2. Removal of reads where the primer could not be identiﬁed
or had a poor alignment score (mismatch rate greater than
0.1).
3. For the MiSeq data, sets of sequences with identical molec-
ular IDs (corresponding to the same mRNA molecule) were
identiﬁed. Sets were collapsed into one consensus sequence
per set, after discarding those having a mean mismatch rate
across all positions >0.2.
4. FortheMiSeqdata,thetwopaired-endreadswereassembled
into a complete Ig sequence.
5. Removal of sequences that do not appear in a single sample
at least twice.
 Assignment of germline V(D)J segments for each of the
Ig sequences: initial V(D)J assignments for each sequence
were obtained using IMGT/HighV-QUEST (27). Using these
assignments, non-mutated sequences were identiﬁed and a V
segmentgermlinerepertoireforeachindividualwasdetermined
as the set of: (1) V genes that composed at least 0.1% of the
sequences,and (2)V gene alleles that composed at least 10% of
the assignments to that V gene. Ig sequences that were initially
assigned V segments not included in this germline repertoire
werethenre-assignedtotheclosestpresentVsegmentbasedon
the Hamming distance.
 Removal of non-functional sequences due to the occurrence of
a stop codon or/and a reading frame shift between the V gene
and the J gene.
 Removal of sequences with more than 30 mutations and mask-
ing(replacementwithNs)ofpositionswithPhredqualityscores
<20.
 Removalof mutationsincodonsthathadmorethanonemuta-
tion, as it is usually not possible to infer the order in which the
mutations occurred (and thus the micro-sequence context of
the mutations is unknown).
 Identiﬁcationofclonallyrelatedsequences:atwo-stepapproach
was applied to identify sequences that were part of a B cell
clone (i.e., related through descent from a common ances-
tor). First, the sequences were divided into groups based on
equivalenceof theirV-geneassignment,J-geneassignment,and
the number of nucleotides in their junction. Second, clones
were deﬁned within each of these groups as the collection of
sequenceswithjunctionregionsthatdifferedfromonesequence
to any of the others by no more than three point mutations.
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FIGURE 5 | Comparison between expected and observed somatic
hypermutation targeting. (A)The predicted mutability from the S5F model
and (B) the observed mutation frequency from sample 3931LN (averaged
over all clones) for each position in the Ig sequence (IMGT-aligned along the
x-axis).The correlation across positions (points) is shown in the inset of (B).
Two positions with evidence of negative selection (red circles) and one
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calling a position with signiﬁcant selection was set to 3 SD away from the
linear regression line (shown as a solid line in the inset, with thresholds
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The threshold of three was determined after manual inspection
of the mutation patterns in resulting clones identiﬁed through
building lineage trees.
4. DISCUSSION
We have constructed new SHM targeting and substitution models
using a collection of more than 800,000 synonymous mutations
from next-generation Ig sequencing studies. The exclusive use of
synonymous mutations allowed us to include mutations from
functional Ig sequences without the biasing inﬂuence of selec-
tion. The large size of the resulting mutation data set allowed us
to model targeting and substitution dependencies on the mutat-
ing base as well as on two bases upstream and downstream of the
mutation.Theresulting“S5F”modelsvalidate,andalsohelpreﬁne,
previously deﬁned SHM hot and cold spots. Figure 4 shows how
the classic WRCY/RGYW hot-spot excludes some highly mutable
WRCA/TGYW motifs,implying that,asproposed by Rogozin and
Diaz (15), WRCH/DGYW could be a better predictor of muta-
tion. However, while the most mutable WRCA/TGYW motifs are
even hotter than WRCY/RGYW, others are comparable to neu-
tral motifs. This high variance demonstrates the importance of
including higher order dependencies, as we have done.
It has been suggested that nucleotide substitution proﬁles are
also dependent on the micro-sequence context of the mutat-
ing base (8, 17). We conﬁrm that the substitution proﬁles at all
nucleotides are highly dependent on neighboring bases and these
dependencies are conserved across individuals. Interestingly, the
fact that substitution rates depend on surrounding bases may
resemble the situation in meiotic mutations as was suggested in
the past (9). The ability of the S5F models to estimate mutability
and substitution at each of the 1024 DNA 5-mer motifs will allow
fordetailed,quantitativecomparisonofSHMwithothermutation
processes.
A potential source of error in the approach taken here is the
existence of novel polymorphisms among the seven individuals
studied (Table 1). Since mutation detection depends on compar-
ison with known V and J segments that are part of the IMGT
repertoire, undetected polymorphisms will look like mutations.
However, any effect on the S5F model is expected to be small
relative to the estimated conﬁdence intervals. Based on a new sta-
tistical tool to detect novel germline alleles from high-throughput
sequencing data (manuscript in preparation), the magnitude of
this effect was estimated to be less than s1% of the sequences and
less than s0.1% of the mutations used for the current analysis.
The S5F mutability and substitution models presented here were
developed using human heavy chain data, and thus may not be
valid for light chains or mouse sequences. Given the large amount
ofsequencingdatabecomingavailable,itmaybepossibletoextend
the proposed approach to model 7-mers instead of 5-mers. How-
ever, even with 5-mers, the values for some motifs had to be
inferred because of the limited diversity in germline repertoires.
It will be important to estimate the quality of these inferences
experimentally. Future experiments might be designed to enrich
fornon-productivelyrearrangedIgsequenceswhichcouldthenbe
sequenced using high-throughput technologies. Since mutations
in these sequences are (presumably) not subject to selection, they
provide a way to independently estimate substitution proﬁles and
mutabilities for at least some of the motifs inferred in the S5F
model. It will be important to conﬁrm that the mutation process
operating on these non-productive sequences is equivalent to the
process at the productive alleles. This uncertainty is one reason
why only productively rearranged Ig sequences were included in
the current model.
The targeting and substitution models developed here provide
a quantitative description of SHM in the absence of selection,
and thus provide an important background for statistical analy-
sis of SHM patterns in experimental data. For example, such
models play an important role in quantifying antigen-driven
selection in Ig sequences (11, 20), and we have now made the
S5F model available as an option on our website for quantify-
ing selection (http://clip.med.yale.edu/baseline).When combined
with high-throughput sequencing, it should now be possible to
quantify selection for each position of the Ig sequence inde-
pendently and link these values back to the physical structure
of the protein. Following the approach of Brard and Guguen
(28), these models could also be incorporated into methods for
building lineage trees of B cell clones (29), thus helping to pro-
vide insight into the underlying population dynamics of adaptive
immunity.Themodelandmethodsourcecodearemadeavailable
at http://clip.med.yale.edu/SHM.
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